LB

Larry Brownstein

Advisor, Investor, Operator

Greater Philadelphia

Overview 

Larry Brownstein is a seasoned advisor, investor, and operator with a strong background in business strategy, commercialization, and sales management. Currently serving as the Chief Operating Officer at CenExel and Hassman Research Institute, he also holds senior advisory roles at Apex Innovative Sciences and Grovara, showcasing his expertise in life sciences, venture capital, and entrepreneurship. Brownstein's notable career highlights include leading sales force development and strategic planning at various organizations, as well as providing mentorship and investment guidance to startups in the healthcare and technology sectors through his roles at Dreamit Ventures and AiCure.

Work Experience 

  • Chief Operating Officer

    2022 - Current

CenExel Clinical Research provides unparalleled medical and scientific support in the design and execution of clinical trials.

  • Advisory Board Member

    2025

  • Chief Operating Officer

    2020

  • Business Advisor - Investor

    2025

  • Business Advisor

    2024

  • Senior Advisor

    2020

  • Investor

    2018

Vuori offers a collection of apparel brands for men and women.

Raised $1,270,000,000.00 from General Atlantic and Stripes.

  • Senior Advisor - Investor

    2020

    Grovara is the 1st B2B Global Marketplace for US Wellness Brands, connecting hundreds of natural and organic brands with international retailers in a single, online marketplace. From product discovery, to order processing and fulfillment, Grovara is reshaping the buying experience, making it easier for B2B buyers and brands to do business. Seed round funding complete $5.5M

Grovara is the 1st B2B Global Marketplace for US Wellness Brands, connecting natural and organic brands with international retailers.

Raised $5,775,000.00 from Ben Franklin Technology Partners of Northeastern Pennsylvania.

  • Advisory Board Member

    2019

ERPHealth is an outcome tracking platform that provides behavioral health care services.

  • Senior Advisor - Investor

    2016

    At AiCure we use artificial intelligence (AI) on mobile devices to confirm medication ingestion in clinical trials and high-risk populations. Series A & B funding - Tribeca Venture Partners, Pritzker Group, New Leaf Venture Partners.

AiCure is an advanced data analytics company that uses artificial intelligence to understand how patients respond to treatments.

Raised $68,750,000.00 from Singtel Innov8, New Leaf Venture Partners, SpringRock Ventures, Asahi Kasei, Silicon Valley Bank, Biomatics Capital Partners, Palisades Growth, Accelmed, Pritzker Group Venture Capital and Tribeca Venture Partners.

Articles About Larry

Relevant Websites